LIN Stock Analysis: Linde Ordinary Shares | NASDAQ

Specialty Chemicals | NASDAQ, USA | Market Cap: 241.506m USD | 12M Return: 25.2% | IE000S9YS762 | Charts, Fundamentals & Technical Analysis

Atmospheric Gases, Process Gases, Engineering Plants, Specialty Gases
Total Rating 62
Safety 64
Buy Signal 0.40
Industrial Gases
Sub-Industry Rotation: +0.0
Market Cap: 242B
Avg Turnover: 1.04B
Risk 3d forecast
Volatility17.7%
VaR 5th Pctl3.09%
VaR vs Median6.12%
Reward TTM
Sharpe Ratio1.07
Rel. Str. IBD72.3
Rel. Str. Peer Group67.3 pctl
Character TTM
Beta0.187
Beta Downside0.277
Hurst Exponent0.412
Choppyness45.4%
Drawdowns 3y
Max DD19.18%
CAGR/Max DD0.47
CAGR/Mean DD1.62
EPS (Earnings per Share) EPS (Earnings per Share) of LIN over the last years for every Quarter: "2021-09": 2.73, "2021-12": 2.77, "2022-03": 2.93, "2022-06": 3.1, "2022-09": 3.1, "2022-12": 3.16, "2023-03": 3.42, "2023-06": 3.57, "2023-09": 3.63, "2023-12": 3.59, "2024-03": 3.75, "2024-06": 3.85, "2024-09": 3.94, "2024-12": 3.97, "2025-03": 3.95, "2025-06": 4.09, "2025-09": 4.21, "2025-12": 4.2, "2026-03": 4.33, "2026-06": 4.5, "2026-09": 4.59,
EPS CAGR: 7.78%
EPS Trend: 99.8%
Last SUE: 4.00
Qual. Beats: 1
Revenue Revenue of LIN over the last years for every Quarter: 2021-09: 7668, 2021-12: 8298, 2022-03: 8211, 2022-06: 8457, 2022-09: 8797, 2022-12: 7899, 2023-03: 8193, 2023-06: 8204, 2023-09: 8155, 2023-12: 8302, 2024-03: 8100, 2024-06: 8267, 2024-09: 8356, 2024-12: 8282, 2025-03: 8112, 2025-06: 8495, 2025-09: 8615, 2025-12: 8764, 2026-03: 8781, 2026-06: 9289, 2026-09: 9404,
Rev. CAGR: 3.36%
Rev. Trend: 89.1%
Last SUE: 1.42
Qual. Beats: 3

Warnings

Below Avwap Earnings

Tailwinds

Confidence

Seasonality 11.9 years of data, until 10/2026

Jan -1.0% 0
Feb +1.1% 0
Mar -0.2% 14
Apr +0.6% 4
May +1.8% 4
Jun +0.4% 28
Jul +0.8% 4
Aug -1.1% 4
Sep -1.8% 47
Oct +1.2% 14
Nov +1.5% 9
Dec -1.1% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: LIN Linde Ordinary Shares

Linde plc is a global industrial gas company headquartered in the United Kingdom and founded in 1879. It produces atmospheric gases such as oxygen, nitrogen, and argon, as well as process gases including hydrogen, helium, carbon dioxide, and specialty gases. Beyond gas production, Linde designs and constructs turnkey process plants, such as air separation and hydrogen facilities, for both internal operations and third-party customers. Its products serve a broad range of end-markets, including healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics, with operations spanning the Americas, Europe, and Asia-Pacific.

The industrial gases sector is defined by high capital intensity and significant barriers to entry, as production facilities such as air separation units require substantial upfront investment and are typically supported by long-term supply agreements with customers. Linde trades on NASDAQ under the ticker LIN and is classified within the Materials sector as a mega-cap stock. The company was formed following the 2018 merger of Germanys Linde AG and U.S.-based Praxair, creating the worlds largest industrial gases business by revenue.

Headlines to Watch Out For
  • Hydrogen project backlog expands across clean energy initiatives
  • Industrial gas pricing benefits from sustained merchant volume growth
  • Backlog strength in electronics gases supports margin expansion
Piotroski VR-10 (Strict) 5.0
Net Income: 7.01b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.13 > 1.0
NWC/Revenue: -6.15% < 20% (prev -8.54%; Δ 2.39% < -1%)
CFO/TA 0.12 > 3% & CFO 10.7b > Net Income 7.01b
Net Debt (23.8b) to EBITDA (13.3b): 1.79 < 3
Current Ratio: 0.86 > 1.5 & < 3
Outstanding Shares: last quarter (462.5m) vs 12m ago -1.91% < -2%
Gross Margin: 37.30% > 18% (prev 37.66%; Δ -0.36% > 0.5%)
Asset Turnover: 41.64% > 50% (prev 38.96%; Δ 2.68% > 0%)
Interest Coverage Ratio: 36.68 > 6 (EBIT TTM 9.46b / Interest Expense TTM 258.0m)
Altman Z'' 2.17
A: -0.03 (Total Current Assets 13.4b - Total Current Liabilities 15.6b) / Total Assets 88.1b
B: 0.22 (Retained Earnings 19.7b / Total Assets 88.1b)
C: 0.11 (EBIT TTM 9.46b / Avg Total Assets 87.0b)
D: 0.84 (Book Value of Equity 39.4b / Total Liabilities 47.1b)
Altman-Z'' = 2.17 = BBB
Beneish M -3.04
DSRI: 0.93 (Receivables 5.59b/5.56b, Revenue 36.2b/33.5b)
GMI: 1.01 (GM 37.66% / 37.30%)
AQI: 0.97 (AQ_t 0.51 / AQ_t-1 0.52)
SGI: 1.08 (Revenue 36.2b / 33.5b)
TATA: -0.04 (NI 7.01b - CFO 10.7b) / TA 88.1b)
Beneish M = -3.04 (Cap -4..+1) = AA
What is the price of LIN shares?

As of November 19, 2026, the stock is trading at USD 512.16 with a total of 1,374,036 shares traded. Over the past week, the price has changed by -2.73%, over one month by +1.73%, over three months by +7.34% and over the past year by +25.17%.

Current recommended Stop Loss: 497.10 (which is 2.9% or 1.7 ATR below the current price).

Is LIN a buy, sell or hold?

Linde Ordinary Shares has received a consensus analysts rating of 4.31. Therefore, it is recommended to buy LIN.

  • StrongBuy: 17
  • Buy: 6
  • Hold: 5
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the LIN price?
Analysts Target Price 551 7.6%
Linde Ordinary Shares (LIN) - Fundamental Data Overview as of 17 November 2026
Market Cap USD = 242b (242b USD * 1.0 USD.USD)
P/E Trailing = 34.9309
P/E Forward = 26.8817
P/S = 6.6644
P/B = 6.1262
P/EG = 2.0657
Revenue TTM = 36.2b USD
EBIT TTM = 9.46b USD
EBITDA TTM = 13.3b USD
Long Term Debt = 20.6b USD (from longTermDebt, last quarter)
Short Term Debt = 6.11b USD (from shortTermDebt, last quarter)
Debt = 27.8b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.08b
Net Debt = 23.8b USD (calculated: Debt 27.8b - CCE 3.95b)
Enterprise Value = 265b USD (242b + Debt 27.8b - CCE 3.95b)
Interest Coverage Ratio = 36.68 (Ebit TTM 9.46b / Interest Expense TTM 258.0m)
EV/FCF = 52.23x (Enterprise Value 265b / FCF TTM 5.08b)
FCF Yield = 1.91% (FCF TTM 5.08b / Enterprise Value 265b)
FCF Margin = 14.02% (FCF TTM 5.08b / Revenue TTM 36.2b)
Net Margin = 19.34% (Net Income TTM 7.01b / Revenue TTM 36.2b)
Gross Margin = 37.30% ((Revenue TTM 36.2b - Cost of Revenue TTM 22.7b) / Revenue TTM)
Gross Margin QoQ = 36.97% (prev 37.30%)
Tobins Q-Ratio = 3.01 (Enterprise Value 265b / Total Assets 88.1b)
Interest Expense / Debt = 0.93% (Interest Expense 258.0m / Debt 27.8b)
Taxrate = 22.86% (2.11b / 9.23b)
NOPAT = 7.30b (EBIT 9.46b * (1 - 22.86%))
Current Ratio = 0.86 (Total Current Assets 13.4b / Total Current Liabilities 15.6b)
Debt / Equity = 0.70 (Debt 27.8b / totalStockholderEquity, last quarter 39.4b)
Debt / EBITDA = 1.79 (Net Debt 23.8b / EBITDA 13.3b)
Debt / FCF = 4.69 (Net Debt 23.8b / FCF TTM 5.08b)
Total Stockholder Equity = 38.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.05% (Net Income 7.01b / Total Assets 88.1b)
RoE = 18.05% (Net Income TTM 7.01b / Total Stockholder Equity 38.8b)
RoCE = 15.93% (EBIT 9.46b / Capital Employed (Equity 38.8b + L.T.Debt 20.6b))
RoIC = 9.51% (NOPAT 7.30b / Invested Capital 76.7b)
WACC = 5.71% (E(242b)/V(269b) * Re(6.28%) + D(27.8b)/V(269b) * Rd(0.93%) * (1-Tc(0.23)))
Discount Rate = 6.28% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.91 | Cagr: -1.92%
[DCF] Terminal Value 75.45% ; FCFF base≈5.08b ; Y1≈5.10b ; Y5≈5.41b
[DCF] Fair Price = 131.4 (EV 84.2b - Net Debt 23.8b = Equity 60.3b / Shares 459.1m; r=8.35% [WACC [floored]]; 5y FCF grow 0.08% → 2.50% )
EPS Correlation: 99.79 | EPS CAGR: 7.78% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.08 | Revenue CAGR: 3.36% | SUE: 1.42 | # QB: 3
EPS current Quarter (2027-03-31): EPS=4.65 | Chg30d=N/A | Revisions=+17% | Analysts=9
EPS current Year (2026-12-31): EPS=17.90 | Chg30d=+0.12% | Revisions=+45% | GrowthEPS=+8.7% | GrowthRev=+7.6%
EPS next Year (2027-12-31): EPS=18.17 | Chg30d=-0.19% | Revisions=-29% | GrowthEPS=+13.2% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +30% (up=16, down=8)